[{"id":"fedc9e7d-89aa-4cee-acd2-a8ecd4f1e103","acronym":"","url":"https://clinicaltrials.gov/study/NCT03094052","created_at":"2021-01-18T15:14:38.972Z","updated_at":"2024-07-02T16:35:28.996Z","phase":"Phase 2","brief_title":"Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib","source_id_and_acronym":"NCT03094052","lead_sponsor":"University of California, San Francisco","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 overexpression • HER-2 amplification","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 overexpression • HER-2 amplification"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Herceptin (trastuzumab) • Nerlynx (neratinib) • Mytesi (crofelemer) • loperamide"],"overall_status":"Completed","enrollment":" Enrollment 11","initiation":"Initiation: 10/09/2018","start_date":" 10/09/2018","primary_txt":" Primary completion: 10/31/2022","primary_completion_date":" 10/31/2022","study_txt":" Completion: 10/31/2022","study_completion_date":" 10/31/2022","last_update_posted":"2023-11-16"},{"id":"8fa22a7d-1e8b-4b2c-ad38-9a1b4c962fe5","acronym":"HALT-D","url":"https://clinicaltrials.gov/study/NCT02910219","created_at":"2021-01-18T14:17:01.373Z","updated_at":"2025-02-25T14:01:06.322Z","phase":"Phase 2","brief_title":"Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients","source_id_and_acronym":"NCT02910219 - HALT-D","lead_sponsor":"Sandra Swain","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 positive","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Herceptin (trastuzumab) • carboplatin • paclitaxel • docetaxel • Perjeta (pertuzumab) • Mytesi (crofelemer)"],"overall_status":"Completed","enrollment":" Enrollment 53","initiation":"Initiation: 01/31/2017","start_date":" 01/31/2017","primary_txt":" Primary completion: 11/23/2020","primary_completion_date":" 11/23/2020","study_txt":" Completion: 11/23/2020","study_completion_date":" 11/23/2020","last_update_posted":"2022-10-24"}]